Related Experiment Video
Updated: Jul 16, 2026

MicroRNA-based Regulation of Picornavirus Tropism
Published on: February 6, 2017
PDTC inhibits picornavirus polyprotein processing and RNA replication by transporting zinc ions into cells
K Lanke1, B M Krenn2, W J G Melchers1
1Department of Medical Microbiology, Radboud University Nijmegen Medical Centre, Nijmegen Centre for Molecular Life Sciences, PO Box 9101, NL-6500 HB Nijmegen, The Netherlands.
Abstract:
Previously, it was shown that pyrrolidine dithiocarbamate (PDTC) inhibits proteolytic polyprotein processing and replication of human rhinovirus by transporting metal ions into cells. Here, it is shown that PDTC also inhibits replication of two other picornaviruses: coxsackievirus B3 (CVB3), a closely related virus that belongs to the genus Enterovirus, and mengovirus, an encephalomyocarditis virus strain that belongs to the genus Cardiovirus, and that this inhibition is due to the dithiocarbamate moiety of the compound. Making use of subgenomic replicons, evidence is provided that PDTC inhibits replication of these two viruses by disturbing viral RNA synthesis. Furthermore, it is shown that PDTC transports zinc ions into cells and that these zinc ions play an important role in the antiviral activity mediated by PDTC. Finally, it is shown that PDTC interferes with proteolytic processing of the polyproteins of both CVB3 and mengovirus, but that the underlying mechanism between these two viruses differs. In CVB3-infected cells, PDTC interferes strongly with the proteolytic activity of 3CD(pro), as shown by the impaired production of the mature capsid proteins as well as the autocleavage of 3CD(pro) into 3C(pro) and 3D(pol). In mengovirus-infected cells, however, PDTC had no effect on the proteolytic production of capsid proteins or the autocleavage of 3CD(pro). Instead, PDTC caused the accumulation of a high-molecular-mass precursor protein, due to an impairment in the primary 'break' that normally occurs at the 2A-2B junction. Thus, PDTC disturbs polyprotein processing and replication of two groups of picornaviruses, enteroviruses and cardioviruses, but the underlying mechanism is different.
Insights
Pyrrolidine dithiocarbamate (PDTC) inhibits replication of enteroviruses and cardioviruses by disrupting viral RNA synthesis and affecting polyprotein processing. This antiviral activity is mediated by zinc ions transported into cells by PDTC.
Area of Science:
- Virology
- Molecular Biology
- Drug Discovery
Background:
- Pyrrolidine dithiocarbamate (PDTC) previously demonstrated inhibition of human rhinovirus replication.
- PDTC's mechanism involved metal ion transport and inhibition of proteolytic polyprotein processing.
Purpose of the Study:
- To investigate PDTC's antiviral activity against other picornaviruses, specifically coxsackievirus B3 (CVB3) and mengovirus.
- To elucidate the mechanisms by which PDTC inhibits replication and polyprotein processing in these viruses.
Main Methods:
- Utilized subgenomic replicons to assess viral RNA synthesis inhibition.
- Investigated the role of zinc ions in PDTC's antiviral effects.
- Analyzed polyprotein processing in CVB3- and mengovirus-infected cells treated with PDTC.
Main Results:
- PDTC inhibited replication of CVB3 (Enterovirus) and mengovirus (Cardiovirus).
- PDTC disturbed viral RNA synthesis in both viruses.
- PDTC transported zinc ions into cells, crucial for its antiviral action.
- PDTC differentially affected polyprotein processing: inhibiting 3CD(pro) activity in CVB3 but impairing the 2A-2B junction cleavage in mengovirus.
Conclusions:
- PDTC exhibits broad-spectrum antiviral activity against picornaviruses, including enteroviruses and cardioviruses.
- The antiviral mechanism involves both disruption of viral RNA synthesis and interference with polyprotein processing.
- PDTC's impact on polyprotein processing varies between virus genera, highlighting distinct viral mechanisms.
Related Concept Videos
Inhibitors of Virion Maturation and Assembly
piRNA - Piwi-interacting RNAs
Inhibitors Of Virion Release
Inhibitors of Viral Protein Synthesis
Negative Regulator Molecules
Antiviral Nucleoside Inhibitors

